82797-423 NDC - ENERJIZER (AVENA SATIVA, ALFALFA, ECHINACEA, GINKGO BILOBA, GINSENG PANAX, CAFFEINUM, GENTIANA LUT, STERCULIA ACUM, CALCIUM PHOSPHATE, CHROMIUM OXIDE, COBALTUM MET, CUPRUM SULPHURICUM, IODIUM, LECITHINUM, MANGANESE SULPHATE, MAGNESIUM OXIDE, KALI MURIATICUM, SELENIUM, ZINC SULPHATE)

Drug Information

  • Product NDC: 82797-423
  • Proprietary Name: Enerjizer
  • Non Proprietary Name: Avena sativa, Alfalfa, Echinacea, Ginkgo biloba, Ginseng panax, Caffeinum, Gentiana Lut, Sterculia Acum, Calcium phosphate, Chromium oxide, Cobaltum met, Cuprum sulphuricum, Iodium, Lecithinum, Manganese sulphate, Magnesium oxide, Kali muriaticum, Selenium, Zinc sulphate
  • Active Ingredient(s): .11392 mg/660mg ALFALFA; .11392 mg/660mg AVENA SATIVA WHOLE; .00128 mg/660mg BASIC COPPER SULFATE; .192 mg/660mg CAFFEINE; .128 mg/660mg CALCIUM PHOSPHATE; .00128 mg/660mg CHROMIC OXIDE; .00128 mg/660mg COBALT; .0576 mg/660mg COLA ACUMINATA WHOLE; .0576 mg/660mg ECHINACEA, UNSPECIFIED; .0576 mg/660mg GENTIANA LUTEA WHOLE; .0128 mg/660mg GINKGO BILOBA WHOLE; .0128 mg/660mg IODINE; .064 mg/660mg LECITHIN, SOYBEAN; .0128 mg/660mg MAGNESIUM OXIDE; .0128 mg/660mg MANGANESE SULFATE; .0128 mg/660mg PANAX GINSENG WHOLE; .0128 mg/660mg POTASSIUM CHLORIDE; .0032 mg/660mg SELENIUM; .0192 mg/660mg ZINC SULFATE
  • Administration Route(s): ORAL
  • Dosage Form(s): TABLET, COATED
  • Pharmacy Class(es): Allergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Cell-mediated Immunity [PE]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Copper Absorption Inhibitor [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Copper Ion Absorption [PE]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibit Ovum Fertilization [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Methylxanthine [EPC]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; Standardized Chemical Allergen [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Xanthines [CS]

Labeler Information

Field Name Field Value
Labeler Name: Dr. Masood Homeopathic Pharmaceuticals Private Limited
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:7/15/2024

Package Information

No. Package Code Package Description Billing Unit
182797-423-3030 mg in 1 BLISTER PACK (82797-423-30)

NDC Record

Field Name Field Value Definition
PRODUCT NDC82797-423The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEEnerjizerThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAvena sativa, Alfalfa, Echinacea, Ginkgo biloba, Ginseng panax, Caffeinum, Gentiana Lut, Sterculia Acum, Calcium phosphate, Chromium oxide, Cobaltum met, Cuprum sulphuricum, Iodium, Lecithinum, Manganese sulphate, Magnesium oxide, Kali muriaticum, Selenium, Zinc sulphateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, COATEDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE7/15/2024This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDr. Masood Homeopathic Pharmaceuticals Private LimitedName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEALFALFA; AVENA SATIVA WHOLE; BASIC COPPER SULFATE; CAFFEINE; CALCIUM PHOSPHATE; CHROMIC OXIDE; COBALT; COLA ACUMINATA WHOLE; ECHINACEA, UNSPECIFIED; GENTIANA LUTEA WHOLE; GINKGO BILOBA WHOLE; IODINE; LECITHIN, SOYBEAN; MAGNESIUM OXIDE; MANGANESE SULFATE; PANAX GINSENG WHOLE; POTASSIUM CHLORIDE; SELENIUM; ZINC SULFATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.11392; .11392; .00128; .192; .128; .00128; .00128; .0576; .0576; .0576; .0128; .0128; .064; .0128; .0128; .0128; .0128; .0032; .0192 
ACTIVE INGRED UNITmg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg; mg/660mg 
PHARM CLASSESAllergens [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cell-mediated Immunity [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ovum Fertilization [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Methylxanthine [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Xanthines [CS] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 4/4/2025

Previous Code
Next Code